These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 27599268)

  • 1. Discovery of Biomarkers for Tasmanian Devil Cancer (DFTD) by Metabolic Profiling of Serum.
    Karu N; Wilson R; Hamede R; Jones M; Woods GM; Hilder EF; Shellie RA
    J Proteome Res; 2016 Oct; 15(10):3827-3840. PubMed ID: 27599268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for induction of humoral and cytotoxic immune responses against devil facial tumor disease cells in Tasmanian devils (Sarcophilus harrisii) immunized with killed cell preparations.
    Kreiss A; Brown GK; Tovar C; Lyons AB; Woods GM
    Vaccine; 2015 Jun; 33(26):3016-25. PubMed ID: 25708088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematologic and serum biochemical changes associated with Devil Facial Tumor Disease in Tasmanian Devils.
    Peck S; Corkrey R; Hamede R; Jones M; Canfield P
    Vet Clin Pathol; 2016 Sep; 45(3):417-29. PubMed ID: 27589840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demonstration of immune responses against devil facial tumour disease in wild Tasmanian devils.
    Pye R; Hamede R; Siddle HV; Caldwell A; Knowles GW; Swift K; Kreiss A; Jones ME; Lyons AB; Woods GM
    Biol Lett; 2016 Oct; 12(10):. PubMed ID: 28120799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Devil Facial Tumor Disease.
    Pye RJ; Woods GM; Kreiss A
    Vet Pathol; 2016 Jul; 53(4):726-36. PubMed ID: 26657222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular vesicle proteomes of two transmissible cancers of Tasmanian devils reveal tenascin-C as a serum-based differential diagnostic biomarker.
    Espejo C; Wilson R; Willms E; Ruiz-Aravena M; Pye RJ; Jones ME; Hill AF; Woods GM; Lyons AB
    Cell Mol Life Sci; 2021 Dec; 78(23):7537-7555. PubMed ID: 34655299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoglubolin dynamics and cancer prevalence in Tasmanian devils (Sarcophilus harrisii).
    Ujvari B; Hamede R; Peck S; Pemberton D; Jones M; Belov K; Madsen T
    Sci Rep; 2016 Apr; 6():25093. PubMed ID: 27126067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curse of the devil: molecular insights into the emergence of transmissible cancers in the Tasmanian devil (Sarcophilus harrisii).
    Patchett AL; Flies AS; Lyons AB; Woods GM
    Cell Mol Life Sci; 2020 Jul; 77(13):2507-2525. PubMed ID: 31900624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doxorubicin and carboplatin trials in Tasmanian devils (Sarcophilus harrisii) with Tasmanian devil facial tumor disease.
    Phalen DN; Frimberger AE; Peck S; Pyecroft S; Harmsen C; Lola S; Moore AS
    Vet J; 2015 Dec; 206(3):312-6. PubMed ID: 26538144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heat shock proteins expressed in the marsupial Tasmanian devil are potential antigenic candidates in a vaccine against devil facial tumour disease.
    Tovar C; Patchett AL; Kim V; Wilson R; Darby J; Lyons AB; Woods GM
    PLoS One; 2018; 13(4):e0196469. PubMed ID: 29702669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-specific diagnostic marker for transmissible facial tumors of Tasmanian devils: immunohistochemistry studies.
    Tovar C; Obendorf D; Murchison EP; Papenfuss AT; Kreiss A; Woods GM
    Vet Pathol; 2011 Nov; 48(6):1195-203. PubMed ID: 21383118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pathology of devil facial tumor disease (DFTD) in Tasmanian Devils (Sarcophilus harrisii).
    Loh R; Bergfeld J; Hayes D; O'hara A; Pyecroft S; Raidal S; Sharpe R
    Vet Pathol; 2006 Nov; 43(6):890-5. PubMed ID: 17099145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization Strategies Producing a Humoral IgG Immune Response against Devil Facial Tumor Disease in the Majority of Tasmanian Devils Destined for Wild Release.
    Pye R; Patchett A; McLennan E; Thomson R; Carver S; Fox S; Pemberton D; Kreiss A; Baz Morelli A; Silva A; Pearse MJ; Corcoran LM; Belov K; Hogg CJ; Woods GM; Lyons AB
    Front Immunol; 2018; 9():259. PubMed ID: 29515577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of season and devil facial tumour disease on the reproductive physiology of the male Tasmanian devil (Sarcophilus harrisii).
    Keeley T; McGreevy PD; O'Brien JK
    Reprod Fertil Dev; 2012; 24(7):999-1007. PubMed ID: 22935161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Season, weight, and age, but not transmissible cancer, affect tick loads in the endangered Tasmanian devil.
    Belkhir S; Hamede R; Thomas F; Ujvari B; Dujon AM
    Infect Genet Evol; 2022 Mar; 98():105221. PubMed ID: 35065301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitogen-activated Tasmanian devil blood mononuclear cells kill devil facial tumour disease cells.
    Brown GK; Tovar C; Cooray AA; Kreiss A; Darby J; Murphy JM; Corcoran LM; Bettiol SS; Lyons AB; Woods GM
    Immunol Cell Biol; 2016 Aug; 94(7):673-9. PubMed ID: 27089941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immunohistochemical characterization of devil facial tumor disease (DFTD) in the Tasmanian Devil (Sarcophilus harrisii).
    Loh R; Hayes D; Mahjoor A; O'Hara A; Pyecroft S; Raidal S
    Vet Pathol; 2006 Nov; 43(6):896-903. PubMed ID: 17099146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regression of devil facial tumour disease following immunotherapy in immunised Tasmanian devils.
    Tovar C; Pye RJ; Kreiss A; Cheng Y; Brown GK; Darby J; Malley RC; Siddle HV; Skjødt K; Kaufman J; Silva A; Baz Morelli A; Papenfuss AT; Corcoran LM; Murphy JM; Pearse MJ; Belov K; Lyons AB; Woods GM
    Sci Rep; 2017 Mar; 7():43827. PubMed ID: 28276463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isotopic niche variation in Tasmanian devils
    Bell O; Jones ME; Cunningham CX; Ruiz-Aravena M; Hamilton DG; Comte S; Hamede RK; Bearhop S; McDonald RA
    Ecol Evol; 2021 Jun; 11(12):8038-8053. PubMed ID: 34188870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunology of a Transmissible Cancer Spreading among Tasmanian Devils.
    Woods GM; Howson LJ; Brown GK; Tovar C; Kreiss A; Corcoran LM; Lyons AB
    J Immunol; 2015 Jul; 195(1):23-9. PubMed ID: 26092814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.